Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Revenue

$656.40M

Quarterly · Period ending: · USD

BIO logo

BIO Revenue

Latest reported$656.40M
BIO Quarterly Revenue ($25.40M → $656.40M)
High-resolution chart · PNG

BIO revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Revenue — Quarterly (USD)
Period endingRevenue (USD)
656,400,000
651,000,000
592,100,000
693,200,000
653,000,000
651,600,000
585,400,000
667,475,000
649,729,000
638,476,000
610,820,000
681,184,000
632,124,000
681,110,000
676,844,000
730,288,000
680,800,000
691,099,000
700,062,000
732,769,000
747,049,000
715,931,000
726,796,000
789,839,000
647,263,000
536,880,000
571,644,000
624,428,000
560,633,000
572,619,000
553,979,000
617,541,000
545,138,000
575,911,000
551,519,000
620,433,000
535,003,000
504,666,000
500,051,000
571,453,000
508,745,000
516,777,000
471,197,000
570,557,000
469,961,000
506,102,000
472,821,000
598,224,000
530,644,000
536,832,000
509,344,000
602,635,000
505,066,000
525,321,000
499,672,000
573,839,000
498,697,000
510,422,000
486,277,000
550,238,000
516,514,000
521,656,000
485,121,000
533,720,000
471,502,000
467,662,000
454,234,000
495,073,000
461,055,000
427,183,000
400,933,000
447,965,000
441,842,000
452,361,000
422,197,000
459,688,000
339,742,000
339,114,000
322,508,000
343,081,000
304,764,000
317,747,000
308,338,000
307,287,000
283,225,000
291,302,000
299,171,000
307,868,000
258,849,000
260,546,000
266,645,000
266,202,000
247,704,000
243,507,000
245,969,000
243,000,000
224,878,000
214,660,000
210,182,000
233,383,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.